# STROBE Statement — Checklist for Cohort Studies

**Study:** Individualized Perioperative ACEI/ARB Management in Cardiac Surgery: A Causal Forest Analysis

| Item No | Recommendation | Reported (Section) |
|---------|---------------|-------------------|
| **Title and Abstract** | | |
| 1 | (a) Indicate the study's design with a commonly used term in the title or the abstract | Title, Abstract |
| | (b) Provide in the abstract an informative and balanced summary of what was done and what was found | Abstract |
| **Introduction** | | |
| 2 | Explain the scientific background and rationale for the investigation being reported | Background |
| 3 | State specific objectives, including any prespecified hypotheses | Background |
| **Methods** | | |
| 4 | Present key elements of study design early in the paper | Methods - Study Design |
| 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection | Methods - Study Setting |
| 6 | (a) Give the eligibility criteria, and the sources and methods of selection of participants | Methods - Participants |
| | (b) For matched studies, give matching criteria and number of exposed and unexposed | Methods - PSM |
| 7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers | Methods - Definitions |
| 8 | For each variable of interest, give sources of data and details of methods of assessment (measurement) | Methods - Data Collection |
| 9 | Describe any efforts to address potential sources of bias | Methods - PSM, Sensitivity |
| 10 | Explain how the study size was arrived at | Methods - Sample Size |
| 11 | Explain how quantitative variables were handled in the analyses | Methods - Statistical Analysis |
| 12 | (a) Describe all statistical methods, including those used to control for confounding | Methods - Statistical Analysis |
| | (b) Describe any methods used to examine subgroups and interactions | Methods - Heterogeneity |
| | (c) Explain how missing data were addressed | Methods - Missing Data |
| | (d) If applicable, describe analytical methods taking account of sampling strategy | Methods - PSM |
| | (e) Describe any sensitivity analyses | Methods - Sensitivity |
| **Results** | | |
| 13 | (a) Report numbers of individuals at each stage of study | Results - Flow diagram |
| | (b) Give reasons for non-participation at each stage | Results - Figure 1 |
| | (c) Consider use of a flow diagram | Figure 1 |
| 14 | (a) Give characteristics of study participants and information on exposures and potential confounders | Results - Table 1 |
| | (b) Indicate number of participants with missing data for each variable of interest | Results - Table S1 |
| 15 | Report numbers of outcome events or summary measures | Results - Table 2 |
| 16 | (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision | Results - Primary Outcome |
| | (b) Report category boundaries when continuous variables were categorized | Results - Subgroup Analysis |
| | (c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period | Results - NNT/NNH |
| 17 | Report other analyses done — e.g., analyses of subgroups and interactions, and sensitivity analyses | Results - Sensitivity |
| **Discussion** | | |
| 18 | Summarise key results with reference to study objectives | Discussion - Summary |
| 19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision | Discussion - Limitations |
| 20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence | Discussion - Interpretation |
| 21 | Discuss the generalisability (external validity) of the study results | Discussion - Generalisability |
| **Other information** | | |
| 22 | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based | Declarations - Funding |
